| dc.contributor.author | Stephenson, Kathryn | |
| dc.contributor.author | Hale, Andrew | |
| dc.contributor.author | Ansel, Jessica | |
| dc.contributor.author | et al. | |
| dc.date.accessioned | 2023-01-12T02:53:12Z | |
| dc.date.available | 2023-01-12T02:53:12Z | |
| dc.date.issued | 2016 | |
| dc.identifier.uri | https://clinicaltrials.gov/ct2/show/NCT02937233 | en_US |
| dc.identifier.uri | https://hdl.handle.net/20.500.12663/3196 | |
| dc.description.abstract | This is a phase 1 trial of one or more administrations of Zika Virus Purified Inactivated Vaccine (ZPIV). The trial will be conducted under a placebo controlled, double-blind, randomized allocation of study product. There are four groups in the study. Each group is testing a different vaccine schedule. | en_US |
| dc.language | English | en_US |
| dc.subject | Zika Research Project | en_US |
| dc.subject | Zika Virus | en_US |
| dc.subject | Vaccines | en_US |
| dc.title | Zika Virus Purifi ed Inactivated Vaccine (ZPIV) Accelerated Vaccination Schedule Study Z001 | en_US |
| eihealth.country | Others | en_US |
| eihealth.category | Epidemiology and epidemiological studies | en_US |
| eihealth.type | Research protocol information | en_US |
| eihealth.maincategory | Save Lives / Salvar Vidas | en_US |
| dc.relation.ispartofjournal | Clinical Trials | en_US |
